Clinical Trials Arena on MSN
Axsome begins Phase III AXS-14 FORWARD trial for fibromyalgia management
Axsome Therapeutics has initiated the FORWARD Phase III trial evaluating AXS-14 for the management of fibromyalgia, with the ...
Axsome Therapeutics AXSM announced the initiation of the phase III study called FORWARD with the dosing of the first patient, ...
Luna Acupuncture & Wellness is expanding its role as a trusted provider of holistic care in Oregon, offering renewed hope to individuals living with fibromyalgia, chronic fatigue, and lingering ...
Interdisciplinary multimodal pain treatment is associated with modest improvements in quality of life among adults with ...
Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...
Once used mainly for distraction, VR is now being studied as a way to retrain the brain’s pain pathways—especially for people ...
A study conducted by British researchers found that patients with fibromyalgia (FM) reported improved quality of life following use of medical cannabis pro | Health And Medicine ...
A new protocol will phenotype chronic ocular surface pain to identify nociplastic CNS drivers using ocular exams, sensory ...
BackFit Health + Spine has earned a 4.9-star aggregate rating from 467 reviews on its Google Business Profile for the ...
Discover essential information about temporomandibular joint disorders (TMDs), their causes, symptoms, diagnosis, and ...
Pain is not a simple sign of damage. New science shows it’s an overprotective alarm system and understanding that could ...
Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results